Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors
Clinical trial NCT00568750 · COMPLETED
Trial details
- NCT number
- NCT00568750
- Sponsor
- Swiss Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-22
- Primary completion
- 2012-01-18
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.